Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects With Super-Refractory Status Epilepticus

To see complete record on, please visit this link

Id: NCT02477618

Organisation Name: Sage Therapeutics

Overal Status: Completed

Start Date: June 2015

Last Update: May 2, 2019

Lead Sponsor: Sage Therapeutics

Brief Summary: This is a randomized, double-blind, placebo-controlled trial, designed to evaluate the efficacy and safety of SAGE-547 administered as a continuous intravenous infusion to subjects in Super-Refractory Status Epilepticus (SRSE).

  • Super-Refractory Status Epilepticus

Total execution time in seconds: 0.30986714363098